🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Ovarian Cancer Stage III

CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride A Study of SHR-A1811 in Subjects With Ovarian Cancer NCT06828354Phase 32 sites📍 Wuhan📍 Jinan Jiangsu HengRui Medicine Co., Ltd. · Tests: SHR-A1811, Paclitaxel Injection, Doxorubicin Hydrochloride Liposome Injection, Gemcitabine Hydrochloride for Injection,… Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer NCT04701645Phase 12 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Microdevice Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors NCT03067181Phase 3629 sites📍 Birmingham📍 Mobile📍 Anchorage Children's Oncology Group · Tests: Best Practice, Biopsy Procedure, Biospecimen Collection, Bleomycin Sulfate, Carboplatin Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer NCT05009082Phase 365 sites📍 Amberg📍 Augsburg📍 Bad Homburg AGO Study Group · Tests: Carboplatin, Paclitaxel, Bevacizumab, Niraparib Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer NCT06580314Phase 3695 sites📍 Birmingham📍 Anchorage📍 Anchorage NRG Oncology · Tests: Bevacizumab, Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging, Olaparib Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer NCT05659381Phase 359 sites📍 Duarte📍 La Jolla📍 Newport Beach GOG Foundation · Tests: Cisplatin, No treatment IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer NCT06394492Phase 32 sites📍 Beijing📍 Hangzhou Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Tests: SHR-A1921, Doxorubicin, Paclitaxel, Topotecan CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer NCT07322094Phase 1, Phase 27 sites📍 Fullerton📍 Irvine📍 Los Angeles TORL Biotherapeutics, LLC · Tests: TORL-1-23 and paclitaxel, TORL-1-23 and carboplatin, TORL-1-23, paclitaxel, and carboplatin Phase III Trial of Stage I Ovarian Cancer After Surgery NCT04063527Phase 3103 sites📍 Nagakute-shi📍 Seto-shi📍 Toyoake-shi Japanese Gynecologic Oncology Group · Tests: adjuvant chemotherapy Interval Cytoreductive Surgery With or Without HIPEC for Ovarian Cancer (FOCUS / KOV-HIPEC-04) NCT05827523Phase 310 sites📍 Sejong📍 Sejong📍 Goyang-si National Cancer Center, Korea · Tests: Cisplatin Chiauranib Plus Weekly Paclitaxel in Patients with Platinum-refractory or Platinum-resistant Recurrent Ovarian Cancer NCT04921527Phase 31 site📍 Shanghai Chipscreen Biosciences, Ltd. · Tests: chiauranib, Placebo, Paclitaxel Utility of Adjusting Chemotherapy Dose & Dosing Schedule With the SALVage Weekly Dose-dense Regimen in Patients With Poor Prognostic OVARian Cancers Based on the Tumor Unfavorable Primary Chemosensitivity and Incomplete Debulking Surgery NCT06476184Phase 376 sites📍 Angers📍 Avignon📍 Avignon ARCAGY/ GINECO GROUP · Tests: Carboplatin, Paclitaxel Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2) NCT04520074Phase 31 site📍 Shanghai Fudan University · Tests: Etoposide, Cyclophosphamide, Carboplatin/Cisplatin Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 NCT05879926Phase 31261 sites📍 Birmingham📍 Anchorage📍 Anchorage NRG Oncology · Tests: Ovarian Function Suppression + Aromatase Inhibitor, Adjuvant Chemotherapy + Ovarian Function Suppression Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer NCT07851025Phase 3186 sites📍 Tampa📍 Baltimore📍 Billings AstraZeneca · Tests: Torvutatug samrotecan, Bevacizumab Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients NCT07460752Phase 21 site📍 Rochester Mayo Clinic · Tests: Biospecimen Collection, Goserelin Acetate, Questionnaire Administration Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors NCT03755739Phase 2, Phase 31 site📍 Guanzhou Second Affiliated Hospital of Guangzhou Medical University · Tests: Checkpoint inhibitor (CPI) such as Pembrolizumab plus chemotherapy MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites📍 Graz📍 Graz📍 Innsbruck Swiss GO Trial Group · Tests: Letrozole 2.5mg, Placebo HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer NCT06855069Phase 31 site📍 Beijing Hansoh BioMedical R&D Company · Tests: HS-20089, Paclitaxel, Doxorubicin, Topotecan Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer NCT04811703Phase 16 sites📍 Lille📍 Lille📍 Lyon Hospices Civils de Lyon · Tests: Combined PIPAC / IV chemotherapy treatment Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy NCT04997096NA1 site📍 Boston Dana-Farber Cancer Institute · Tests: Exercise, Attention Control Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer NCT05284552Phase 28 sites📍 Eksjö📍 Gothenburg📍 Jönköping University Hospital, Linkoeping · Tests: Tinzaparin Injectable Solution MITO 35B: Olaparib Beyond Progression Compared to Platinum Chemotherapy After Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer Patients. NCT05255471Phase 31 site📍 Naples National Cancer Institute, Naples · Tests: Olaparib, Chemotherapy drug The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer NCT07636200NA2 sites📍 Aurora📍 Boulder University of Colorado, Boulder · Tests: Written Exposure-Based Coping Intervention (EASE), Usual Care Control Condition Newly Diagnosed Stage III/IV Ovarian Cancer, Neoadjuvant Carbo/Taxol/Pembro, Maintenance Olaparib/Pembro NCT05952453Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Carboplatin, olaparibp, embro Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian Cancer NCT07816666Phase 3124 sites📍 Anchorage📍 Miami📍 Indianapolis AstraZeneca · Tests: Torvutatug samrotecan, Bevacizumab PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer NCT07472140Phase 2, Phase 31 site📍 Minsk N.N. Alexandrov National Cancer Centre · Tests: PARP inhibitor + Bevacizumab, PARP inhibitor Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax NCT05092373Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib S-malate, Nab-paclitaxel, Tumor Treating Fields Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy